HOMEAboutAssure Programs response to global COVID-19 outbreak

Assure Programs response to global COVID-19 outbreak

Plan for the continued safe delivery of our services – updated 4/3/2020

*For support on matters related to the COVID-19 situation, please view our range of articles on our Major Event Resources page.

As a leading global human services provider, Assure Programs is closely monitoring the spread of the COVID-19 (“coronavirus”) pathogen.

As always our first priority is the safety of our clients and staff. All Assure Programs offices are closely monitoring their local situation and following the advice of medical health authorities and immediately reporting any suspected cases. Given much of our work is face-to-face, Assure Programs has suspended all international travel for staff to high risk countries while ensuring that all recent personal and business travel is reported and, where necessary, staff are quarantined. Any staff who recently travelled to a high risk country cannot return to work unless they have a medical clearance.

In addition, Assure Programs has implemented its Universal Infection Control Guidelines and reinforced the need for all staff to exercise proper hygiene to help reduce the spread COVID-19.

The most recent list of high risk countries is: China; Hong Kong (including Macau); Thailand; Japan; Korea, Singapore; Indonesia; Malaysia; Taiwan; Iran; and Italy.

If you are an Assure Programs client and have recently visited one of these countries and are scheduled for a meeting with one of our staff, please contact the office and postpone the meeting. If you are feeling unwell, immediately contact your doctor or seek advice from a hospital. Medical authorities warn that the following symptoms could indicate COVID-19 infection: fever; breathing difficulties such as breathlessness; cough; sore throat; fatigue or tiredness.

Assure Programs will continue to closely monitor the spread of COVID-19 and update our web site with any new advice.

For additional updates, follow us on LinkedIn.